With $29.3M from the Gates Foundation, Rockville company opens plant today.

With the grant by the Bill and Melinda Gates Foundation announced Thursday, plus a new partnership with the Malaria Vaccine Initiative, Sanaria has reached $45 million in funding for developing a malaria vaccine.

While Sanaria Inc. works to keep its focus on developing revenue streams, the estimated 3,000 children who die each day in a global resurgence of malaria add a humanitarian perspective for the Rockville company. This week, Sanaria, headed by CEO Stephen Hoffman, begins manufacturing its first run of a unique and promising malaria vaccine.